Anthralin USP Powder for Compounding (API)

Anthralin USP Powder for Compounding (API) is used to formulate topical medications for the treatment of psoriasis. It works by slowing down the rapid growth of skin cells, reducing scaling, inflammation, and plaque formation associated with psoriasis. Anthralin, known for its cytostatic properties, helps manage symptoms and improve skin appearance. Compounding allows pharmacists to create specific strengths and formulations tailored to individual patient needs, maximizing therapeutic efficacy and minimizing potential irritation, thus offering effective psoriasis management.

Anthralin USP Powder is a chemical compound used in the pharmaceutical industry to treat various skin disorders, such as psoriasis and eczema. It is also known as dithranol and is a synthetic derivative of a natural substance found in the bark of the araroba tree. Anthralin has anti-inflammatory and anti-proliferative properties, making it effective in reducing the thickness and scaling of psoriasis lesions. It is often used as an active ingredient in compounded medications for topical application.

Anthralin is an active ingredient found in certain prescription topical creams and ointments. It is used for the treatment of inflammatory skin conditions such as psoriasis and eczema. It works by slowing down the growth of skin cells and reducing inflammation. Anthralin may also have antibacterial and antifungal properties, making it effective in treating certain skin infections. It is considered a safe and effective treatment option for mild to moderate cases of psoriasis.